InnoDrug Introduction
InnoDrug Group Limited is a global biopharmaceutical enterprise registered in the Cayman Islands. The Group’s international headquarters and R&D center—InnoDrug Lab. (HongKong) Co., Limited—is established at Hong Kong Science Park and has received dedicated funding support from the Hong Kong Government’s Incu-Bio program. We focus on full value chain operations from drug discovery and clinical development to commercialization, with a pipeline of 20 original innovative drugs with global patents across three major therapeutic areas: cardiovascular and cerebrovascular diseases, metabolic and inflammatory immune disorders, and oncology.
Group Structure
We have established a strategic network covering the globe, including wholly-owned subsidiaries and R&D centers in Singapore, the United States, Macao, and multiple core cities in mainland China. We are actively expanding into ASEAN and East Asian markets to achieve global resource integration and commercial operations.
